2015
DOI: 10.1111/pme.12549
|View full text |Cite
|
Sign up to set email alerts
|

Use of a Medication Quantification Scale for Comparison of Pain Medication Usage in Patients with Complex Regional Pain Syndrome (CRPS)

Abstract: There appears to be only a weak correlation between amount of pain medication prescribed and patients' reported subjective pain intensity within this limited patient population. The Medication Quantification Scale is a viable tool for the analysis of pharmaceutical treatment of CRPS patients and would be useful in further prospective studies of pain medication prescription practices in the CRPS population worldwide.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
7
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 14 publications
(7 citation statements)
references
References 26 publications
0
7
0
Order By: Relevance
“…Furthermore, a correlation has been found between the reduction of the total score of MQS and the pain intensity reduction at the back and in the leg. In parallel to this study, Gallizzi et al investigated the correlation of MQS in patients with complex regional pain syndrome (CRPS) and their VAS scores (35). In contrast to our study, they did not find, with exception of the data from Germany ( r = 0.465, p = 0.039), any correlations between MQS and pain intensity.…”
Section: Discussionmentioning
confidence: 98%
“…Furthermore, a correlation has been found between the reduction of the total score of MQS and the pain intensity reduction at the back and in the leg. In parallel to this study, Gallizzi et al investigated the correlation of MQS in patients with complex regional pain syndrome (CRPS) and their VAS scores (35). In contrast to our study, they did not find, with exception of the data from Germany ( r = 0.465, p = 0.039), any correlations between MQS and pain intensity.…”
Section: Discussionmentioning
confidence: 98%
“…The MQS score is a validated score to evaluate medication usage. This quasi‐quantitative outcome measure was developed in 1992, subsequently revised and validated in 1998 and 2003, and is specifically used for chronic non‐malignant pain 29–32 . The scoring system is a composite one derived from combining detriment weight, daily dosage, and the putative nature of the mechanism of action of drugs.…”
Section: Discussionmentioning
confidence: 99%
“…This quasi-quantitative outcome measure was developed in 1992, subsequently revised and validated in 1998 and 2003, and is specifically used for chronic non-malignant pain. [29][30][31][32] The scoring system is a composite one derived from combining detriment weight, daily dosage, and the putative nature of the mechanism of action of drugs. This is useful for the assessment of individual patients and to monitor change over time.…”
Section: Discussionmentioning
confidence: 99%
“…So this might have influenced the reported pain intensity but also disease burden. However, Gallizzi et al (2015) found at best a low correlation between prescribed pain medication and pain intensity. Another limitation is the large difference in the disease duration.…”
Section: Discussionmentioning
confidence: 82%